Overview
- 9 FDA inspections are on record.
- 3 inspections produced a Form 483.
- The most recent recorded inspection date is 2026-01-21.
At a glance
Inspections
9
Form 483s
3
EIRs
0
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 12 Jan 2026 – 21 Jan 2026 | Human Drugs | 483 | On file |
| 4 Jun 2025 – 5 Jun 2025 | Foods & Cosmetics | Clean | |
| 27 Feb 2023 – 11 Apr 2023 | Human Drugs | 483 | View 483 → |
| 15 Dec 2015 – 18 Dec 2015 | Human Drugs | Clean | |
| 4 Jun 2013 – 7 Jun 2013 | Human Drugs | Clean | |
| 7 Mar 2011 | Not recorded | Clean | |
| 7 May 2010 | Not recorded | 483 | View 483 → |
| 20 Oct 2008 | Not recorded | Clean | |
| 5 May 2004 | Not recorded | Clean |
Observations on record
Form 483 observations cited at this site, most recent first.
Investigators
FDA investigators tied to this site in the record.
James D Bridges3 insp.
Lauren H Augustyniak1 insp.
Yuyan Liang1 insp.
William J Leonard1 insp.
Karen L Kosar1 insp.
Marc S Neubauer1 insp.
Kimberley A Ricketts1 insp.
Joseph J Vannelli1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.166(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.194(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.198(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.22(d) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.46(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.84(d)(1) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind LPNA Group Inc.'s 3 Form 483s
Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat